{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2011:EDLGHHO2JUOIWHCEFHVYEDJY5K","short_pith_number":"pith:EDLGHHO2","schema_version":"1.0","canonical_sha256":"20d6639dda4d1c8b1c4429eb820d38ea8754e534c4c8578692a3334c76e04f36","source":{"kind":"arxiv","id":"1108.1614","version":1},"attestation_state":"computed","paper":{"title":"Bayesian phase I/II adaptively randomized oncology trials with combined drugs","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Guosheng Yin, Ying Yuan","submitted_at":"2011-08-08T07:12:21Z","abstract_excerpt":"We propose a new integrated phase I/II trial design to identify the most efficacious dose combination that also satisfies certain safety requirements for drug-combination trials. We first take a Bayesian copula-type model for dose finding in phase I. After identifying a set of admissible doses, we immediately move the entire set forward to phase II. We propose a novel adaptive randomization scheme to favor assigning patients to more efficacious dose-combination arms. Our adaptive randomization scheme takes into account both the point estimate and variability of efficacy. By using a moving refe"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1108.1614","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2011-08-08T07:12:21Z","cross_cats_sorted":[],"title_canon_sha256":"7966f96a21267a5c92fc101bedf2f0c43f4158eb7295b15d0d82fef266079409","abstract_canon_sha256":"1c71073508face53ba5ca6c62748e88e25feac91ab3fab9b070a67a905da26bf"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T04:16:00.577478Z","signature_b64":"h4bqiKqdeF9QcC+0jYSlIa6RoJ/bV+1PQMISZgR+DpTjOkcJ4IdarDQTPhlBedsdCxPlK1fmWAQ3/T4PhIdZAA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"20d6639dda4d1c8b1c4429eb820d38ea8754e534c4c8578692a3334c76e04f36","last_reissued_at":"2026-05-18T04:16:00.576900Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T04:16:00.576900Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Bayesian phase I/II adaptively randomized oncology trials with combined drugs","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Guosheng Yin, Ying Yuan","submitted_at":"2011-08-08T07:12:21Z","abstract_excerpt":"We propose a new integrated phase I/II trial design to identify the most efficacious dose combination that also satisfies certain safety requirements for drug-combination trials. We first take a Bayesian copula-type model for dose finding in phase I. After identifying a set of admissible doses, we immediately move the entire set forward to phase II. We propose a novel adaptive randomization scheme to favor assigning patients to more efficacious dose-combination arms. Our adaptive randomization scheme takes into account both the point estimate and variability of efficacy. By using a moving refe"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1108.1614","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1108.1614","created_at":"2026-05-18T04:16:00.576998+00:00"},{"alias_kind":"arxiv_version","alias_value":"1108.1614v1","created_at":"2026-05-18T04:16:00.576998+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1108.1614","created_at":"2026-05-18T04:16:00.576998+00:00"},{"alias_kind":"pith_short_12","alias_value":"EDLGHHO2JUOI","created_at":"2026-05-18T12:26:28.662955+00:00"},{"alias_kind":"pith_short_16","alias_value":"EDLGHHO2JUOIWHCE","created_at":"2026-05-18T12:26:28.662955+00:00"},{"alias_kind":"pith_short_8","alias_value":"EDLGHHO2","created_at":"2026-05-18T12:26:28.662955+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K","json":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K.json","graph_json":"https://pith.science/api/pith-number/EDLGHHO2JUOIWHCEFHVYEDJY5K/graph.json","events_json":"https://pith.science/api/pith-number/EDLGHHO2JUOIWHCEFHVYEDJY5K/events.json","paper":"https://pith.science/paper/EDLGHHO2"},"agent_actions":{"view_html":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K","download_json":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K.json","view_paper":"https://pith.science/paper/EDLGHHO2","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1108.1614&json=true","fetch_graph":"https://pith.science/api/pith-number/EDLGHHO2JUOIWHCEFHVYEDJY5K/graph.json","fetch_events":"https://pith.science/api/pith-number/EDLGHHO2JUOIWHCEFHVYEDJY5K/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K/action/timestamp_anchor","attest_storage":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K/action/storage_attestation","attest_author":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K/action/author_attestation","sign_citation":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K/action/citation_signature","submit_replication":"https://pith.science/pith/EDLGHHO2JUOIWHCEFHVYEDJY5K/action/replication_record"}},"created_at":"2026-05-18T04:16:00.576998+00:00","updated_at":"2026-05-18T04:16:00.576998+00:00"}